{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:53:39Z","timestamp":1781636019168,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81760098"],"award-info":[{"award-number":["81760098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81760098"],"award-info":[{"award-number":["81760098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81760098"],"award-info":[{"award-number":["81760098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangxi Province Key Laboratory of Child Development","award":["2024SSY06191"],"award-info":[{"award-number":["2024SSY06191"]}]},{"name":"Jiangxi Province Key Laboratory of Child Development","award":["2024SSY06191"],"award-info":[{"award-number":["2024SSY06191"]}]},{"name":"Jiangxi Province Key Laboratory of Child Development","award":["2024SSY06191"],"award-info":[{"award-number":["2024SSY06191"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aims to explore the functions and mechanisms underlying the involvement of 14-3-3\u03b2 in esophageal squamous cell carcinoma (ESCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Western blot and quantitative real-time PCR (RT-PCR) were utilized to evaluate the levels of 14-3-3\u03b2 in SHEE, TE-1, and KYSE-150 cells. Following infection with YWHAB-RNAi lentivirus and puromycin screening, the reduction of 14-3-3\u03b2 expression in KYSE-150 cells was confirmed via western blot and RT-PCR. Subsequently, wound healing, CCK8, and colony-formation assays were performed to assess cell migration and proliferation in KYSE-150 cells with stable low levels of 14-3-3\u03b2. Furthermore, western blot analysis was conducted to examine the expression of relevant proteins, elucidating the potential molecular mechanisms underlying 14-3-3\u03b2 involvement in ESCC progression and metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression of 14-3-3\u03b2 was significantly elevated in KYSE-150 cells compared to SHEE cells. Upon infection in KYSE-150 cells, the expression of 14-3-3\u03b2 was diminished, resulting in suppressed cell migration and colony formation, although no significant changes were observed in the CCK8 assays. Furthermore, in KYSE-150 cells exhibiting reduced 14-3-3\u03b2 expression, the activity of phosphorylated AKT (p-AKT) was significantly decreased, while no notable difference was detected in AKT protein levels. Additionally, there were no significant alterations observed in apoptosis-related proteins, including BCL2, BAX, Caspase3, and activated Caspase9.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In KYSE-150 cells infected with YWHAB-RNAi lentivirus, the downregulation of 14-3-3\u03b2 expression resulted in significant reductions in both cell migration and proliferation. Furthermore, the findings demonstrated that 14-3-3\u03b2 may regulate the biological activities of ESCC cells via modulation of the PI3K\/AKT signaling pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00651-4","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T08:25:08Z","timestamp":1770798308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["14-3-3\u03b2 knockdown inhibits migration and colony formation of esophageal squamous cell carcinoma cells and is associated with weakened p-AKT signaling"],"prefix":"10.1186","volume":"163","author":[{"given":"Qing-Hua","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Qin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Shi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Bin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"issue":"39","key":"651_CR1","doi-asserted-by":"publisher","first-page":"16457","DOI":"10.1039\/d1nr04015d","volume":"13","author":"Q Zhu","year":"2021","unstructured":"Zhu Q, Huang L, Yang Q, Ao Z, Yang R, Krzesniak J, Lou D, Hu L, Dai X, Guo F, Liu F. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma. Nanoscale. 2021;13(39):16457\u201364. https:\/\/doi.org\/10.1039\/d1nr04015d.","journal-title":"Nanoscale"},{"key":"651_CR2","doi-asserted-by":"publisher","DOI":"10.2174\/1874467216666230306101653","volume":"17","author":"Z Ma","year":"2024","unstructured":"Ma Z, Zhu T, Wang H, Wang B, Fu L, Yu G. E2F1 reduces sorafenib\u2019s sensitivity of esophageal carcinoma cells via modulating the miR-29c-3p\/COL11A1 signaling axis. Curr Mol Pharmacol. 2024;17:e060323214360. https:\/\/doi.org\/10.2174\/1874467216666230306101653.","journal-title":"Curr Mol Pharmacol"},{"issue":"8","key":"651_CR3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2174\/1874467216666230130132927","volume":"16","author":"L Hu","year":"2023","unstructured":"Hu L, Cao H, Zheng L, Li R. BBOX1-AS1 activates Hedgehog signaling pathway to facilitate the proliferation and stemness of esophageal squamous cell carcinoma cells via miR-506-5p\/EIF5A\/PTCH1 axis. Curr Mol Pharmacol. 2023;16(8):894\u2013904. https:\/\/doi.org\/10.2174\/1874467216666230130132927.","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"651_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00898-0","volume":"20","author":"W Su","year":"2022","unstructured":"Su W, Hu H, Ding Q, Wang M, Zhu Y, Zhang Z, et al. NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143. Cell Commun Signal. 2022;20(1):87. https:\/\/doi.org\/10.1186\/s12964-022-00898-0.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"651_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095386","volume":"9","author":"YJ Qi","year":"2014","unstructured":"Qi YJ, Wang M, Liu RM, Wei H, Chao WX, Zhang T, et al. Downregulation of 14-3-3\u03c3 correlates with multistage carcinogenesis and poor prognosis of esophageal squamous cell carcinoma. PLoS One. 2014;9(4):e95386. https:\/\/doi.org\/10.1371\/journal.pone.0095386.","journal-title":"PLoS One"},{"issue":"2","key":"651_CR6","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.3892\/mmr.2017.8144","volume":"17","author":"Q Wu","year":"2018","unstructured":"Wu Q, Zhu J, Liu F, Liu J, Li M. Downregulation of 14-3-3\u03b2 inhibits proliferation and migration in osteosarcoma cells. Mol Med Rep. 2018;17(2):2493\u2013500. https:\/\/doi.org\/10.3892\/mmr.2017.8144.","journal-title":"Mol Med Rep"},{"issue":"1\u20132","key":"651_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jns.2008.08.040","volume":"276","author":"X Yang","year":"2009","unstructured":"Yang X, Cao W, Lin H, Zhang W, Lin W, Cao L, Zhen H, Huo J, Zhang X. Isoform-specific expression of 14-3-3 proteins in human Astrocytoma. J Neurol Sci. 2009;276(1\u20132):54\u20139. https:\/\/doi.org\/10.1016\/j.jns.2008.08.040.","journal-title":"J Neurol Sci"},{"issue":"1","key":"651_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146070","volume":"11","author":"Y Tang","year":"2016","unstructured":"Tang Y, Lv P, Sun Z, Han L, Zhou W. 14-3-3\u03b2 promotes migration and invasion of human hepatocellular carcinoma cells by modulating expression of MMP2 and MMP9 through PI3K\/Akt\/NF-\u03baB pathway. PLoS One. 2016;11(1):e0146070. https:\/\/doi.org\/10.1371\/journal.pone.0146070.","journal-title":"PLoS One"},{"issue":"3","key":"651_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ijc.20492","volume":"113","author":"W Qi","year":"2005","unstructured":"Qi W, Liu X, Qiao D, Martinez JD. Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer. 2005;113(3):359\u201363. https:\/\/doi.org\/10.1002\/ijc.20492.","journal-title":"Int J Cancer"},{"issue":"25","key":"651_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3760\/cma.j.issn.1673-4904.2014.25.001","volume":"37","author":"JY Wang","year":"2014","unstructured":"Wang JY, Li XJ, Zhang ZQ, Zhang B. Expression and clinical significance of 14-3-3\u03b2 in esophageal squamous carcinoma tissues. Chin J Physician Adv. 2014;37(25):1\u20135. https:\/\/doi.org\/10.3760\/cma.j.issn.1673-4904.2014.25.001.","journal-title":"Chin J Physician Adv"},{"key":"651_CR11","doi-asserted-by":"publisher","unstructured":"Li XJ, Zhang QQ, Li J, Guo Y, Yao JJ, Wen GZ, Zhang ZQ. Establishment of esophageal squamous carcinoma cell lines with different invasive metastatic potential and differential gene screening. J Physiol Pharmacol. 2022;73(4). https:\/\/doi.org\/10.26402\/jpp.2022.4.02.","DOI":"10.26402\/jpp.2022.4.02"},{"issue":"5","key":"651_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/1566523222666220825110147","volume":"24","author":"C Liu","year":"2024","unstructured":"Liu C, Shi J, Lin B, Zhou M, Shan D, Nie J, et al. SHR6390 combined with cabozantinib inhibits tumor progression in the hepatocellular carcinoma mouse model. Curr Gene Ther. 2024;24(5):453\u201364. https:\/\/doi.org\/10.2174\/1566523222666220825110147.","journal-title":"Curr Gene Ther"},{"issue":"1","key":"651_CR13","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1186\/s12885-022-09787-8","volume":"22","author":"J Guo","year":"2022","unstructured":"Guo J, Yang Q, Wei S, Shao J, Zhao T, Guo L, Liu J, Chen J, Wang G. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma. BMC Cancer. 2022;22(1):745. https:\/\/doi.org\/10.1186\/s12885-022-09787-8.","journal-title":"BMC Cancer"},{"issue":"1","key":"651_CR14","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/annonc\/mdx279","volume":"28","author":"G Murphy","year":"2017","unstructured":"Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo MC, Dar NA, et al. International cancer seminars: a focus on esophageal squamous cell carcinoma. Ann Oncol. 2017;28(1):2086\u201393. https:\/\/doi.org\/10.1093\/annonc\/mdx279.","journal-title":"Ann Oncol"},{"issue":"1","key":"651_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1006\/excr.2001.5376","volume":"271","author":"RR Subramanian","year":"2001","unstructured":"Subramanian RR, Masters SC, Zhang H, Fu H. Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. Exp Cell Res. 2001;271(1):142\u201351. https:\/\/doi.org\/10.1006\/excr.2001.5376.","journal-title":"Exp Cell Res"},{"issue":"24","key":"651_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep41254","volume":"7","author":"Z Peng","year":"2017","unstructured":"Peng Z, Wang Y, Fan J, Lin X, Liu C, Xu Y, et al. Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc\/p53 and AKT\/14-3-3 pathway. Sci Rep. 2017;7(24):41254. https:\/\/doi.org\/10.1038\/srep41254.","journal-title":"Sci Rep"},{"issue":"6","key":"651_CR17","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1016\/j.ajpath.2011.08.010","volume":"179","author":"TA Liu","year":"2011","unstructured":"Liu TA, Jan YJ, Ko BS, Chen SC, Liang SM, Hung YL, Hsu C, Shen TL, Lee YM, Chen PF, Wang J, Shyue SK, Liou JY. Increased expression of 14-3-3\u03b2 promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma. Am J Pathol. 2011;179(6):2698\u2013708. https:\/\/doi.org\/10.1016\/j.ajpath.2011.08.010.","journal-title":"Am J Pathol"},{"issue":"6","key":"651_CR18","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.3892\/or.2013.2740","volume":"30","author":"F Gong","year":"2013","unstructured":"Gong F, Wang G, Ye J, Li T, Bai H, Wang W. 14-3-3\u03b2 regulates the proliferation of glioma cells through the GSK3\u03b2\/\u03b2-catenin signaling pathway. Oncol Rep. 2013;30(6):2976\u201382. https:\/\/doi.org\/10.3892\/or.2013.2740.","journal-title":"Oncol Rep"},{"issue":"6","key":"651_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0092-8674(00)81067-3","volume":"84","author":"AJ Muslin","year":"1996","unstructured":"Muslin AJ, Tanner JW, Allen PM, Shaw AS. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell. 1996;84(6):889\u201397. https:\/\/doi.org\/10.1016\/s0092-8674(00)81067-3.","journal-title":"Cell"},{"issue":"3","key":"651_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/s0092-8674(02)01083-8","volume":"111","author":"DP Brazil","year":"2002","unstructured":"Brazil DP, Park J, Hemmings BA. PKB binding proteins. Getting in on the Akt. Cell. 2002;111(3):293\u2013303. https:\/\/doi.org\/10.1016\/s0092-8674(02)01083-8.","journal-title":"Cell"},{"issue":"7","key":"651_CR21","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1158\/1535-7163.MCT-17-0823","volume":"17","author":"M Song","year":"2018","unstructured":"Song M, Liu X, Liu K, Zhao R, Huang H, Shi Y, et al. Targeting AKT with Oridonin inhibits growth of esophageal squamous cell carcinoma in vitro and patient-derived xenografts in vivo. Mol Cancer Ther. 2018;17(7):1540\u201353. https:\/\/doi.org\/10.1158\/1535-7163.MCT-17-0823.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"651_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0855-7","volume":"37","author":"J Jiang","year":"2018","unstructured":"Jiang J, Xu Y, Ren H, Wudu M, Wang Q, Song X, et al. MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K\/Akt pathway. J Exp Clin Cancer Res. 2018;37(1):189. https:\/\/doi.org\/10.1186\/s13046-018-0855-7.","journal-title":"J Exp Clin Cancer Res"},{"key":"651_CR23","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.2147\/CMAR.S311192","volume":"13","author":"B Hui","year":"2021","unstructured":"Hui B, Pan S, Che S, Sun Y, Yan Y, Guo J, Gong T, Ren J, Zhang X. Silencing UHRF1 enhances radiosensitivity of esophageal squamous cell carcinoma by inhibiting the PI3K\/Akt\/mTOR signaling pathway. Cancer Manag Res. 2021;13:4841\u201352. https:\/\/doi.org\/10.2147\/CMAR.S311192.","journal-title":"Cancer Manag Res"},{"issue":"11","key":"651_CR24","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","volume":"1813","author":"G Tzivion","year":"2011","unstructured":"Tzivion G, Dobson M, Ramakrishnan G. FoxO transcription factors; regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta. 2011;1813(11):1938\u201345. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.06.002.","journal-title":"Biochim Biophys Acta"},{"issue":"44","key":"651_CR25","doi-asserted-by":"publisher","first-page":"6331","DOI":"10.1038\/sj.onc.1204777","volume":"20","author":"G Tzivion","year":"2001","unstructured":"Tzivion G, Shen YH, Zhu J. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene. 2001;20(44):6331\u20138. https:\/\/doi.org\/10.1038\/sj.onc.1204777.","journal-title":"Oncogene"},{"issue":"7","key":"651_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC. Akt\/PKB signaling: navigating downstream. Cell. 2007;129(7):1261\u201374. https:\/\/doi.org\/10.1016\/j.cell.2007.06.009.","journal-title":"Cell"},{"issue":"3","key":"651_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/carcin\/bgi228","volume":"27","author":"D Xiao","year":"2006","unstructured":"Xiao D, Singh SV. Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells. Carcinogenesis. 2006;27(3):533\u201340. https:\/\/doi.org\/10.1093\/carcin\/bgi228.","journal-title":"Carcinogenesis"},{"issue":"12","key":"651_CR28","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1080\/09168451.2020.1808443","volume":"84","author":"H Endo","year":"2020","unstructured":"Endo H, Inoue I, Masunaka K, Tanaka M, Yano M. Curcumin induces apoptosis in lung cancer cells by 14-3-3 protein-mediated activation of Bad. Biosci Biotechnol Biochem. 2020;84(12):2440\u20137. https:\/\/doi.org\/10.1080\/09168451.2020.1808443.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"11","key":"651_CR29","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s41417-022-00474-1","volume":"29","author":"T Yang","year":"2022","unstructured":"Yang T, Zhu C, Shi Y, Shen Y, Gao Y, Zhang B, Jin R, Liu D, Ouyang Y, Liu X, Wang W, Yang P, Xu Q, Cai J, Chen D. RDIVpSGP motif of ASPP2 binds to 14-3-3 and enhances ASPP2\/k18\/14-3-3 ternary complex formulation to promote BRAF\/MEK\/ERK signal inhibited cell proliferation in hepatocellular carcinoma. Cancer Gene Ther. 2022;29(11):1616\u201327. https:\/\/doi.org\/10.1038\/s41417-022-00474-1.","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"651_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ccell.2015.01.005","volume":"27","author":"P ten Dijke","year":"2015","unstructured":"ten Dijke P, van Dam H. 14-3-3\u03b6 turns TGF-\u03b2 to the dark side. Cancer Cell. 2015;27(2):151\u20133. https:\/\/doi.org\/10.1016\/j.ccell.2015.01.005.","journal-title":"Cancer Cell"},{"issue":"4","key":"651_CR31","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2024.14602","volume":"28","author":"X Geng","year":"2024","unstructured":"Geng X, Yuan J, Xu W, Zou D, Sun Y, Li J. YWHAB is regulated by IRX5 and inhibits the migration and invasion of breast cancer cells. Oncol Lett. 2024;28(4):469. https:\/\/doi.org\/10.3892\/ol.2024.14602.","journal-title":"Oncol Lett"},{"issue":"7","key":"651_CR32","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1021\/pr9011377","volume":"9","author":"S Zuo","year":"2010","unstructured":"Zuo S, Xue Y, Tang S, Yao J, Du R, Yang P, et al. 14-3-3 epsilon dynamically interacts with key components of mitogen-activated protein kinase signal module for selective modulation of the TNF-alpha-induced time course-dependent NF-kappaB activity. J Proteome Res. 2010;9(7):3465\u201378. https:\/\/doi.org\/10.1021\/pr9011377.","journal-title":"J Proteome Res"},{"issue":"1","key":"651_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-019-0200-8","volume":"5","author":"Y Qiu","year":"2019","unstructured":"Qiu Y, Shan W, Yang Y, Jin M, Dai Y, Yang H, et al. Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3\u03b7\/hypoxia-inducible factor-1\u03b1. Cell Death Discov. 2019;5(1):120. https:\/\/doi.org\/10.1038\/s41420-019-0200-8.","journal-title":"Cell Death Discov"},{"issue":"05","key":"651_CR34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.13865\/j.cnki.cjbmb.2023.03.1593","volume":"39","author":"QQ Zhu","year":"2023","unstructured":"Zhu QQ, Jiao YL, Ruan HJ, Wu DR, Guo R, Sun K, et al. Porphyromonas gingivalis regulates programmed death-1 protein degradation through 14-3-3\u03c3 in esophageal squamous cell carcinoma. J Biochem Mol Biol. 2023;39(05):734\u201340. https:\/\/doi.org\/10.13865\/j.cnki.cjbmb.2023.03.1593.","journal-title":"J Biochem Mol Biol"},{"issue":"09","key":"651_CR35","first-page":"290","volume":"32","author":"ZJ Wang","year":"2011","unstructured":"Wang ZJ, Zhang Q, Li D. The inhibitory effect of Baicalin on human esophageal adenocarcinoma OE33 cells. Food Sci Technol. 2011;32(09):290\u20134.","journal-title":"Food Sci Technol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00651-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00651-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:04:49Z","timestamp":1781633089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00651-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["651"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00651-4","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with approval from the Ethics Committee of Jiangxi Provincial Children\u2019s Hospital (Approval Number: JXSETYY-YXKY-20180009). This study was conducted in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}